The effect of imprecise repositioning on lesion volume measurements in patients with multiple sclerosis

In this study, we evaluated the effect of imprecision in patient repositioning encountered in real life on multiple sclerosis (MS) lesion volumes measured from MRIs. We also evaluated two putative methods for reducing the variability in these lesion volume measurements: first, a reduction of slice thickness (from the conventional 5 mm to 3 mm) and second, the application of a new repositioning technique based on the use of head immobilization shells. We evaluated the errors in lesion volume by scanning 10 patients a total of four times using the two slice thicknesses and two repositioning methods (conventional and using a head immobilization shell). The mean absolute percentage difference between two corresponding scans was 6.8% (range, 1.24 to 11%) using conventional slice thickness and repositioning, 4.1% (range, 0.7 to 5.56%) using conventional slice thickness and head immobilization shells, 2.6% (range, 0.8 to 6.66%) using the conventional repositioning technique and 3-mm slice thickness, and 1.4%(range, 0.2 to 6.14%) using slice thickness of 3 mm and head immobilization shells. These mean absolute differences were significantly different(p = 0.0008). Our results indicate that the effect of repositioning errors of the order of those that can be encountered in the daily life situation of clinical trials affects significantly lesion load measurements in MS and that the combined use of thinner slices and more accurate repositioning techniques can markedly improve the reproducibility of such measurements.

[1]  C. Cunningham-Rundles,et al.  Encephalomyelitis in primary hypogammaglobulinaemia. , 1996, Brain : a journal of neurology.

[2]  C Becker,et al.  Quantitative assessment of MRI lesion load in multiple sclerosis. A comparison of conventional spin-echo with fast fluid-attenuated inversion recovery. , 1996, Brain : a journal of neurology.

[3]  G. Comi,et al.  Resolution-dependent estimates of lesion volumes in MRI studies of the brain in multiple sclerosis , 1995, Journal of Neuroimmunology.

[4]  M. Horsfield,et al.  Quantitative assessment of MRI lesion load in monitoring the evolution of multiple sclerosis. , 1995, Brain : a journal of neurology.

[5]  John R. Hodges,et al.  Progressive prosopagnosia associated with selective right temporal lobe atrophy. A new syndrome? , 1995, Brain : a journal of neurology.

[6]  R. Rosenberg Autosomal dominant cerebellar phenotypes , 1990, Neurology.

[7]  J. Ross,et al.  The effect of repositioning error on serial magnetic resonance imaging scans. , 1993, Archives of neurology.

[8]  W. Nitz,et al.  MP RAGE: a three-dimensional, T1-weighted, gradient-echo sequence--initial experience in the brain. , 1992, Radiology.

[9]  S. Medendorp,et al.  Magnetic resonance imaging lesion enlargement in multiple sclerosis. Disease-related activity, chance occurrence, or measurement artifact? , 1992, Archives of neurology.

[10]  A. Thompson,et al.  Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[11]  P. Ell,et al.  99TCm-HMPAO SPECT studies in traumatic intracerebral haematoma. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[12]  J. Kurtzke Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[13]  J. Ebersole,et al.  An evaluation of ambulatory, cassette EEG monitoring , 1983, Neurology.

[14]  M. Raichle The pathophysiology of brain ischemia , 1983, Annals of neurology.